✦ LIBER ✦

Raltegravir for HIV-1 infections approved by European Commission

Book ID: 120845295
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816200-00057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raltegravir raises the BENCHMRK for trea

Raltegravir raises the BENCHMRK for treating HIV-1 infections

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 163 KB

Maraviroc approved in the US for HIV-1 i

Maraviroc approved in the US for HIV-1 infections

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Darunavir conditionally approved for HIV

Darunavir conditionally approved for HIV-1 infections in EU

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Raltegravir with Optimized Background Th

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

✍ Steigbigel, Roy T.; Cooper, David A.; Kumar, Princy N.; Eron, Joseph E.; Schecht 📂 Article 📅 2008 🏛 Massachusetts Medical Society 🌐 English ⚖ 324 KB

Health Canada approves atazanavir for HI

Health Canada approves atazanavir for HIV-1 infection

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Are European-specific guidelines needed

Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?

✍ Yazdan Yazdanpanah; Sue J Goldie; Roger Salamon; Yves Mouton; Kenneth A Freedber 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 37 KB